This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...

Shares of several pharmaceutical companies were up after President Trump signed an executive order aimed at accelerating research, development access to psychedelic medicines for the treatment of ...

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

We'll know more about the company's medium-term prospects by the end of the year.

Regeneron is the latest pharmaceutical manufacturer to make a deal with the administration to offer some of their drugs at ...

If biotech funding continues to increase this year, Danaher could benefit.

ORLANDO, FL / ACCESS Newswire / April 21, 2026 / RedChip Companies, an industry leader in investor relations, media, ...

(NASDAQ:KYMR) is among the best biotech stocks. TheFly reported on April 13 that KYMR announced that the U.S. Food and Drug ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

The promise of a better pan-RAS inhibitor Erasca has been described as the poor man’s Revolution Medicines. Impoverished ...

The increase in nationwide vacancy to 23.2% is a reversal from the slight dip to end 2025, according to preliminary CBRE data ...

The full picture of Replimune's layoffs is coming into focus — and more employees are on the chopping block than previously ...